- Home
- BTU vs BCRX Comparison
BTU vs BCRX Comparison
Compare BTU & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTU
- BCRX
- Stock Information
- Founded
- BTU 2016
- BCRX 1986
- Country
- BTU United States
- BCRX United States
- Employees
- BTU N/A
- BCRX N/A
- Industry
- BTU Coal Mining
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTU Energy
- BCRX Health Care
- Exchange
- BTU Nasdaq
- BCRX Nasdaq
- Market Cap
- BTU 1.7B
- BCRX 1.7B
- IPO Year
- BTU N/A
- BCRX 1994
- Fundamental
- Price
- BTU $12.84
- BCRX $7.40
- Analyst Decision
- BTU Strong Buy
- BCRX Buy
- Analyst Count
- BTU 5
- BCRX 6
- Target Price
- BTU $24.60
- BCRX $15.67
- AVG Volume (30 Days)
- BTU 7.0M
- BCRX 3.2M
- Earning Date
- BTU 05-01-2025
- BCRX 05-05-2025
- Dividend Yield
- BTU 2.34%
- BCRX N/A
- EPS Growth
- BTU N/A
- BCRX N/A
- EPS
- BTU 2.70
- BCRX N/A
- Revenue
- BTU $4,236,700,000.00
- BCRX $450,712,000.00
- Revenue This Year
- BTU N/A
- BCRX $27.64
- Revenue Next Year
- BTU $14.76
- BCRX $13.42
- P/E Ratio
- BTU $4.71
- BCRX N/A
- Revenue Growth
- BTU N/A
- BCRX 36.00
- 52 Week Low
- BTU $9.61
- BCRX $4.03
- 52 Week High
- BTU $29.94
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- BTU 49.55
- BCRX 50.46
- Support Level
- BTU $11.06
- BCRX $6.02
- Resistance Level
- BTU $13.05
- BCRX $7.41
- Average True Range (ATR)
- BTU 1.03
- BCRX 0.44
- MACD
- BTU 0.14
- BCRX 0.06
- Stochastic Oscillator
- BTU 75.82
- BCRX 81.66
About BTU Peabody Energy Corporation
Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.